IGF2 and osteosarcoma: Shimizu et al. have demonstrated that IGF2 induces autophagic dormancy, helping osteosarcoma cells withstand chemotherapy [46], while autocrine IGF1 signaling, in the absence of oncogenic drivers, mediates the dormancy of pancreatic tumor cells [47].